Please find below the details of the All.Can International "Building efficiency in cancer care" policy blueprint virtual launch event hosted by MEP Tomislav Sokol.
Date: 23 February 2022
//-->
Please find below the details of the All.Can International "Building efficiency in cancer care" policy blueprint virtual launch event hosted by MEP Tomislav Sokol.
Date: 23 February 2022
October is Liver Cancer Awareness Month (LCAM).
The webinar seeks to connect decision-makers and all relevant stakeholders to discuss ‘Recommendations from the iPAAC Joint Action how to tackle challenges in Cancer Care and improve its Governance in the EU'.
Despite advances in cancer diagnoses and effective therapies which have helped to increase survival rates, cancer survivors continue to experience significant challenges.
Non-melanoma skin cancer (NMSC) is by far the most frequently diagnosed cancer around the globe.
ECPC started a global campaign on the Joint letter on COVID-19 and cancer and invited stakeholders around the globe to endorse the letter.
We are happy to invite you to our next public event: “EU Joint Action on Rare Cancers (JARC) recommendations towards implementing the Rare Cancer Agenda 2030” that will take place on Wednesday, 24th of F
On 19 February 2021 from 10:30 – 12:30 (CET), an online event entitled “14 Million Reasons to Discuss Life after Cancer: Implementing the Right to be Forgotten acro
We are inviting you to attend our online webinar on Head and neck cancer which will take place on Wednesday, 25th November 2020 from 15:00 to 16:00 CET.
We are inviting you to attend our
We are inviting you to attend our online webinar "Biosimilars Explained: What Patients Need To Know" which will take place on Tuesday, 13th October 2020 from 15:00 to 16:0
On 9 June, 11:00 AM, the European Cancer Patient Coalition will be organising an online event entitled “There is Life after Cancer: Putting an end to the discrimination&r
The European Cancer Patient Coalition, together with MEP Marlene Mizzi (S&D, Malta), is organising an event on the topic of Cancer Biomarkers in the Era of Personalised Medicines.
Hosted by MEP Heinz K. Becker (EPP, Austria)
ECPC wants to contribute to raise awareness about bladder cancer. The White Paper to be launched on 20 April 2016 is an appeal to policy makers, the scientific and medical community to reduce the burden of bladder cancer on patients.
Head and neck cancer is the 6th most common type of cancer in Europe with more than 150,000 new patients diagnosed in 2012, and the incidence of the disease is on the rise.